Critical factors for the management of patients with primary gliomas are the definition of grade and spatial extent of the tumor. While tissue histology is the gold standard for diagnosis of grade, the possibility of sampling error and inability to perform multiple repeat biopsies have meant that the evaluation of tumor extent and the assessment of response to therapy rely heavily upon non-invasive imaging techniques. Although Magnetic Resonance Imaging (MRI) provides data with excellent soft tissue contrast and is widely used for serial evaluation of patients with brain tumors, the observed changes reflect abnormalities in tissue morphology rather than functional characteristics. Distinguishing tumor from edema, inflammation and treatment induced necrosis would be greatly facilitated by obtaining additional information concerning physiological properties of the tissue. Over the past five years we have developed a combined MRI and water suppressed proton spectroscopic imaging (MRSI) examination for the quantitative assessment of tumor extent and response to therapy based upon changes in morphologic abnormalities, hemodyamtic parameters and levels of cellular metabolites. In the current proposal we will apply these techniques to patients with suspected gliomas in order to establish baseline MR parameters for newly diagnosed gliomas, to determine whether there is evidence for these parameters being predictive of outcome and to evaluate response to focal beam radiation therapy. Our hypotheses are (1) that there is a difference between levels of choline, cretaine, N-acetylaspartate and relative cerebral blood volume (rCBV) between gliomas of grades II, III and IV, (2) that there are significant differences between the spatial extent of the Gadolinium enhancing lesion, T2-weighted abnormality, metabolic and hemodynamic abnormalities and (3) that regions which respond positively to focal beam radiation therapy for patients with Grades II and III gliomas display a reduction in choline, creatine, N- acetylaspartate and rCBV, whereas regions corresponding to tumor recurrence exhibit increases in rCBV and choline. It is anticipated that these studies will provide information which will be valuable for tailoring treatment protocols to individual patients, targeting biopsies, surgical resection or focal radiation therapy, evaluating response to therapy and understanding the mechanisms of treatment failure.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA079719-03
Application #
6329051
Study Section
Special Emphasis Panel (ZRG7-DMG (04))
Program Officer
Menkens, Anne E
Project Start
1998-12-23
Project End
2003-11-30
Budget Start
2001-02-15
Budget End
2001-11-30
Support Year
3
Fiscal Year
2001
Total Cost
$338,591
Indirect Cost
Name
University of California San Francisco
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Osorio, Joseph A; Xu, Duan; Cunningham, Charles H et al. (2009) Design of cosine modulated very selective suppression pulses for MR spectroscopic imaging at 3T. Magn Reson Med 61:533-40
McKnight, Tracy R; Lamborn, Kathleen R; Love, Tonya D et al. (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 106:660-6
Catalaa, Isabelle; Henry, Roland; Dillon, William P et al. (2006) Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed 19:463-75
Li, Xiaojuan; Vigneron, Daniel B; Cha, Soonmee et al. (2005) Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol 26:760-9
Oh, Joonmi; Henry, Roland G; Pirzkall, Andrea et al. (2004) Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 19:546-54
Li, Xiaojuan; Jin, Hua; Lu, Ying et al. (2004) Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 17:10-20
Pirzkall, Andrea; Li, Xiaojuan; Oh, Joonmi et al. (2004) 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 59:126-37
Nelson, Sarah J (2004) Magnetic resonance spectroscopic imaging. Evaluating responses to therapy for gliomas. IEEE Eng Med Biol Mag 23:30-9
Lee, Michael C; Pirzkall, Andrea; McKnight, Tracy R et al. (2004) 1H-MRSI of radiation effects in normal-appearing white matter: dose-dependence and impact on automated spectral classification. J Magn Reson Imaging 19:379-88
Nelson, Sarah J; Cha, Soonmee (2003) Imaging glioblastoma multiforme. Cancer J 9:134-45

Showing the most recent 10 out of 17 publications